For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
Menu
For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
Menu
For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
Twitter
Facebook-f
News
All
Press
Media
Events
Other
Kyoto University Students Visit I Peace’s Head Office
•
September 19, 2023
•
Other
I Peace was featured on TV Tokyo’s Program
•
July 3, 2023
•
Other
I Peace, Inc. honored in BioSpectrum Asia Excellence Award 2022 with “Special Recognition in Cell Therapy”
•
December 22, 2022
•
Press
I Peace partners with the California Institute for Regenerative Medicine [CIRM]
•
November 1, 2022
•
Other
CEO Koji Tanabe presents at the 2022 International Summit Forum on Cell Therapy and Regenerative Medicine in Taiwan
•
October 28, 2022
•
Events
GMP cell CDMO I Peace, Inc. in collaboration with universities successfully converted human dermal fibroblasts into oligodendrocyte by direct reprogramming
•
September 20, 2022
•
Press
I Peace in the News – the Nikkei on, 2022
•
August 3, 2022
•
Media
A new automated iPSC high-throughput induction system to induce thousands of iPSC lines simultaneously
To be presented at ISSCR 2022 Annual Meeting
•
June 15, 2022
•
Press
I Peace accelerates allogeneic iPSC-derived cell therapies with a high throughput method to identify a large number of donors with specific HLA haplotypes
•
May 12, 2022
•
Press
I Peace triples GMP cell manufacturing by expanding CDMO facility
•
March 14, 2022
•
Press
Reach out to us to learn more
Contact Us